Ajanta Pharma Ltd.

AJANTPHARM

Market Cap
₹30,001 Cr.
P/E
36.76

Ajanta Pharma Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
17.35%
3yr Average
20.34%
5yr Average
19.25%
Net Profit Margin
Latest
15.71%
3yr Average
19.89%
5yr Average
19.31%
ROCE
Latest
21.07%
3yr Average
24.92%
5yr Average
24.04%
Debt to Equity
Latest
0.0
3yr Average
0.0
5yr Average
0.01
Market Share
0.19% (as of Jul 22)
Anti - Diabetes - Market Share
0.14% (as of Jul 22)
Anti-Infectives - Market Share
2.14% (as of Jul 22)
Cardiovascular - Market Share
1.54% (as of Nov 21)
Dermatology - Market Share
0.01% (as of Jan 21)
Endocrinology - Market Share
0.02% (as of Jul 22)
Gastro-Intestinal - Market Share
0.01% (as of Apr 21)
Gynecology - Market Share
0.28% (as of Nov 21)
Neurological - Market Share
9.51% (as of Nov 21)
Ophthalmology - Market Share
0.66% (as of Nov 21)
Pain - Market Share
0.70% (as of Dec 22)
Pharmaceutical Sector - Market Share
0.14% (as of Nov 21)
Respiratory - Market Share
0% (as of Jul 22)
Sex Stimulants - Market Share
0.06% (as of Nov 21)
Stomatological - Market Share
0.17% (as of Nov 21)
Urology - Market Share
0.16% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Segment Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Branded Generics

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Ajanta Pharma Ltd.
    View the discussion on ValuePickr
    Ajanta Pharma - What makes it special? - ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline